Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT06374160
Eligibility Criteria:
Inclusion Criteria
* Patients with histologically confirmed non-small cell lung carcinoma in UICC stages IIIB and IV
* First- or second-line therapy (inclusion up to 28 days after the first cycle) in palliative intention
* Age ≥ 18 years
* Signed informed consent
Exclusion Criteria
* Severe cardiopulmonary disease (EF\<30%)
* Newly occurring or progressive uncontrolled CNS (central nervous system) metastases
* Expected life expectancy \< 3 months
* Bone metastases with acute risk of fracture
* ECOG (Eastern Cooperative Oncology Group) performance status \> 2
* Acute pulmonary embolism
* Acute myocardial infarction
* Requiring surgery for aortic aneurysm
* Tension pneumothorax
* Lack of proficiency in the German language
* Active infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06374160
Study Brief:
Protocol Section:
NCT06374160